We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$8.27B
AUM Growth
+$1.17B
Cap. Flow
+$791M
Cap. Flow %
9.57%
Top 10 Hldgs %
43.67%
Holding
1,071
New
101
Increased
574
Reduced
272
Closed
122

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$299M
2
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$268M
3
AAPL icon
Apple
AAPL
+$63.9M
4
MSFT icon
Microsoft
MSFT
+$62.6M
5
FXI icon
iShares China Large-Cap ETF
FXI
+$61.1M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$189M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$111M
3
V icon
Visa
V
+$56.7M
4
MA icon
Mastercard
MA
+$48.1M
5
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$41.9M

Sector Composition

Rank Sector Weight
1 Technology 27.46%
2 Financials 14.83%
3 Healthcare 4.08%
4 Consumer Discretionary 3.56%
5 Industrials 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVAX icon
376
Novavax
NVAX
$1.22B
$2.25M 0.03%
20,788
-170
-0.8% -$20.7K
INSM icon
377
Insmed
INSM
$21.3B
$2.24M 0.03%
69,685
+34,564
+98% +$993K
WAL icon
378
Western Alliance Bancorporation
WAL
$9.04B
$2.24M 0.03%
70,773
+11,060
+19% +$394K
ACAD icon
379
Acadia Pharmaceuticals
ACAD
$4.39B
$2.23M 0.03%
54,181
+33,346
+160% +$1.44M
EXEL icon
380
Exelixis
EXEL
$13.8B
$2.23M 0.03%
91,309
+27,955
+44% +$653K
LNC icon
381
Lincoln National
LNC
$8.82B
$2.21M 0.03%
70,712
+20,579
+41% +$735K
RARE icon
382
Ultragenyx Pharmaceutical
RARE
$2.46B
$2.21M 0.03%
26,873
+12,840
+91% +$1.06M
TYL icon
383
Tyler Technologies
TYL
$12.5B
$2.21M 0.03%
6,338
+1,603
+34% +$554K
ARCT icon
384
Arcturus Therapeutics
ARCT
$171M
$2.21M 0.03%
+51,404
New +$2.55M
BLUE
385
DELISTED
bluebird bio
BLUE
$2.2M 0.03%
3,153
+1,999
+173% +$1.56M
TPTX
386
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2.2M 0.03%
25,209
+15,116
+150% +$1.05M
BPOP icon
387
Popular Inc
BPOP
$11.1B
$2.2M 0.03%
60,623
+7,824
+15% +$290K
MHO icon
388
M/I Homes
MHO
$3.8B
$2.2M 0.03%
47,725
+7,264
+18% +$302K
ANET icon
389
Arista Networks
ANET
$233B
$2.19M 0.03%
169,408
+48,688
+40% +$669K
DCPH
390
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.19M 0.03%
42,630
+25,012
+142% +$1.23M
BHVN
391
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.19M 0.03%
33,608
+19,137
+132% +$1.25M
SPH icon
392
Suburban Propane Partners
SPH
$1.25B
$2.18M 0.03%
133,913
+34,878
+35% +$478K
SAGE
393
DELISTED
Sage Therapeutics
SAGE
$2.18M 0.03%
35,603
+9,224
+35% +$467K
FOLD
394
DELISTED
Amicus Therapeutics
FOLD
$2.17M 0.03%
153,931
+66,546
+76% +$970K
BEP icon
395
Brookfield Renewable
BEP
$10.2B
$2.17M 0.03%
61,814
+580
+0.9% +$17.1K
ZBRA icon
396
Zebra Technologies
ZBRA
$13.9B
$2.14M 0.03%
8,464
+2,140
+34% +$576K
SRPT icon
397
Sarepta Therapeutics
SRPT
$1.68B
$2.13M 0.03%
15,181
+9,109
+150% +$1.38M
TGTX icon
398
TG Therapeutics
TGTX
$7.07B
$2.13M 0.03%
79,653
+24,096
+43% +$554K
BLDR icon
399
Builders FirstSource
BLDR
$7.8B
$2.09M 0.03%
64,154
+9,358
+17% +$254K
EBS icon
400
Emergent Biosolutions
EBS
$382M
$2.09M 0.03%
20,231
+3,754
+23% +$405K
14 15
16
17 18

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return

Rafferty Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Rafferty Asset Management held 1,071 positions worth $8.27B, up 17% from $7.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rafferty Asset Management deployed $791M of net new capital in Q3 2020, opening 101 new positions and adding to 574 existing holdings. Its largest new stake was INPHI CORPORATION: 63,139 shares worth $7.09M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $189M trimmed.

  • Rafferty Asset Management's largest Q3 2020 buy was INPHI CORPORATION: 63,139 shares worth $7.09M.
  • Rafferty Asset Management added most to VanEck Gold Miners ETF in Q3 2020, an estimated $299M increase.
  • Rafferty Asset Management's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $189M.
  • Rafferty Asset Management fully exited iShares Russell 1000 ETF in Q3 2020, selling an estimated $19.9M.
  • Rafferty Asset Management's ten largest holdings make up 44% of its $8.27B portfolio in Q3 2020.
  • Rafferty Asset Management opened 101 new positions and closed 122 in Q3 2020.
  • Rafferty Asset Management's portfolio value rose 17% quarter-over-quarter to $8.27B.

Based on Rafferty Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.